SCHEMBL13792022

SCHEMBL13792022

CCNC(=O)OCC1(NC(C)C)CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.45
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ EPHX1 P07099 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CYP2C9 P11712 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ APEX1 P27695 1/20 0.31
▸ CTSK P43235 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13804483 0.84 ALDH1A1 (0.47) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL13791853 0.84 CHRNB2 (0.37) CHRNB2CHRNA4EPHX1SMN1; SMN2CYP2C9
SCHEMBL13792021 0.76 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL8374989 0.71 ALDH1A1 (0.54) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL12584816 0.68 CHRNB2 (0.36) ALDH1A1CHRNB2CHRNA4EPHX1SMN1; SMN2
SCHEMBL26670733 0.66 CYP2C19 (0.37) ALDH1A1KMT2ACYP2C9L3MBTL1CTSK
SCHEMBL15461455 0.66 GAA (0.42) ALDH1A1MEN1KMT2AL3MBTL1KDM4E
SCHEMBL24004507 0.66 MME (0.35) —
SCHEMBL12787697 0.65 SMN1; SMN2 (0.54) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL13070545 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550559-B2 Acylsulfonamide compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2009-06-23 — — US disclosed
US-7399749-B2 Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-07-15 — — US disclosed
US-7342041-B2 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
Send feedback